Risk factors may include
Decreased blood flow, hypovolemia
Increased levels of hemoglobin in the blood
Failure of oxygen transport
Interrupting the flow of venous blood (thrombosis)
It is obvious from
(Not, the presence of symptoms of a real diagnosis)
Desired outcomes / evaluation criteria, the client
Maintaining adequate perfusion not individually hot and dry skin, peripheral pulses are present and strong, and vital signs are within limits.
Determine the cause or risk factors.
To demonstrate behaviors to improve and maintain traffic.
Nursing interventions on the ground:
1st Monitor vital signs, palpation of peripheral pulses and capillary regular evaluation of performance and changes in performance. Note: 24 hours hydration.
Justification: Indicators of circulatory adequacy.
Promoting a second regular series of motion (ROM) exercises for the legs and ankles. Maintain a schedule of gradual compression device (SCD) of the lower limbs, where they are used.
Background: It stimulates the blood circulation in the legs, reduce risk complications associated with venous stasis, such as deep vein thrombosis and pulmonary embolism (PE).
3rd Evaluation of red, swelling and discomfort in the body.
Justification: Indicators of coagulation, but the signs are not always present in obese people.
Encourage walking to early fourth session suspension foot of the bed to discourage.
Justification: The meeting of the reduced venous flow, while walking to facilitate the venous return.
5th Adequate and appropriate facilities, including the conversion of trapeze, transfer equipment, wheelchair and walker and sufficient staff to customers.
Background: useful in the treatment of obese clients and moving ambulating. Reducing the risk of traumatic injury to clients and caregivers.
6th Evaluation of complications, such as hard braking, nonincisional abdominal pain, fever, tachycardia and hypotension.
Background: Although rare, the client developing abdominal complications such as abdominal compartment syndrome, sepsis or septic shock secondary anastomotic leakage or wound infection requiring intensive intervention or return after surgery.
Seventh that heparin therapy, as indicated.
Background: it can be used to reduce the risk of clot formation or to treat thromboemboli.
8th Monitor hemoglobin (HGB), hematocrit (HCl), and coagulation studies including prothrombin time (PT) and international normalized ratio (INR).
Background: Provides information on the volume and circulatory changes in the treatment of bleeding and to identify needs and efficiency.